scholarly journals Generic alendronate use among medicare beneficiaries: are part d data complete?

2012 ◽  
Vol 22 (1) ◽  
pp. 55-63 ◽  
Author(s):  
Huifeng Yun ◽  
Jeffrey R Curtis ◽  
Kenneth Saag ◽  
Meredith Kilgore ◽  
Paul Muntner ◽  
...  
Keyword(s):  
Medicare Beneficiaries ◽  
Part D ◽  
Generic Alendronate

scholarly journals PNS105 ASSOCIATION OF LOW-INCOME SUBSIDY/DUAL ELIGIBILITY AND DISABILITY WITH HIGH-RISK MEDICATION USE AMONG PART D MEDICARE BENEFICIARIES

2020 ◽  
Vol 23 ◽  
pp. S303
Author(s):  
C. Chinthammit ◽  
S. Bhattacharjee ◽  
M. Slack ◽  
W. Lo-Ciganic ◽  
J.P. Bentley ◽  
...  
Keyword(s):  
High Risk ◽  
Low Income ◽  
Medication Use ◽  
Medicare Beneficiaries ◽  
Part D ◽  
Dual Eligibility

scholarly journals MD3 EVALUATING THE WILLINGNESS-TO-PAY OF MEDICARE BENEFICIARIES FOR PART D PLAN ASSISTANCE

2011 ◽  
Vol 14 (3) ◽  
pp. A11
Author(s):  
R.A. Patel ◽  
M.P. Walberg ◽  
J. Na ◽  
D. Hsiou ◽  
V. Panchal ◽  
...  
Keyword(s):  
Willingness To Pay ◽  
Medicare Beneficiaries ◽  
Part D

Medicare Part D is Associated With Reducing the Financial Burden of Health Care Services in Medicare Beneficiaries With Diagnosed Diabetes

Medical Care ◽  
2013 ◽  
Vol 51 (10) ◽  
pp. 888-893 ◽  
Author(s):  
Rui Li ◽  
Edward W. Gregg ◽  
Lawrence E. Barker ◽  
Ping Zhang ◽  
Fang Zhang ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Services ◽  
Financial Burden ◽  
Medicare Part D ◽  
Medicare Part ◽  
Medicare Beneficiaries ◽  
Part D ◽  
Care Services ◽  
Diagnosed Diabetes

scholarly journals ME4 THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION AND HEALTH OF THE MEDICARE BENEFICIARIES

2010 ◽  
Vol 13 (3) ◽  
pp. A7
Author(s):  
FX Liu ◽  
GC Alexander ◽  
SY Crawford ◽  
AS Pickard ◽  
DR Hedeker ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Medicare Part D ◽  
Medicare Part ◽  
Care Utilization ◽  
Medicare Beneficiaries ◽  
Part D ◽  
The Impact

scholarly journals Comparative Usability Study of a Newly Created Patient-Centered Tool and Medicare.gov Plan Finder to Help Medicare Beneficiaries Choose Prescription Drug Plans

2018 ◽  
Vol 6 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Cheryl D Stults ◽  
Sayeh Fattahi ◽  
Amy Meehan ◽  
M Kate Bundorf ◽  
Albert S Chan ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Selection Process ◽  
Ease Of Use ◽  
Usability Study ◽  
Medicare Beneficiaries ◽  
Patient Centered ◽  
Part D ◽  
Drug Plan ◽  
Plan Selection ◽  
Expert Recommendations

Introduction: In response to reported difficulties in selecting a Medicare Part D prescription drug plan, we designed a patient-centered online Part D plan selection tool (CHOICE1.0) to simplify the selection process and to provide personalized, expert recommendations. Methods: This ethnographic comparative usability study observed 44 patients using the first version of the tool during Medicare 2016 Open Enrollment. Participants were observed as they chose their drug plan using Medicare.gov and 1 of 3 versions of CHOICE1.0 that varied in amount of expert guidance. Descriptive statistics were used to analyze exit survey data. The observations were video-recorded, and field notes were analyzed thematically. Results: Participants were significantly more satisfied with CHOICE1.0 for choosing a plan, understanding information, and ease of use compared to Medicare.gov . Those using expert versions of CHOICE1.0 were more likely to indicate their intention to switch plans than those using Medicare.gov , though they wanted to know the source and content. Conclusion: The more patient-centered prescription drug choice tool improved user experience and enabled users to choose plans more consistent with expert recommendations.

Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries

2016 ◽  
Vol 75 (2) ◽  
pp. 153-174
Author(s):  
G. Caleb Alexander ◽  
Cuiping Schiman ◽  
Robert Kaestner
Keyword(s):  
Length Of Stay ◽  
Medicare Part D ◽  
Care Utilization ◽  
Medicare Beneficiaries ◽  
Medicare Current Beneficiary Survey ◽  
Part D ◽  
Drug Insurance ◽  
Clinically Significant ◽  
Instrumental Variables Approach ◽  
Mean Charge

Medicare Part D was associated with reduced hospitalizations, yet little is known whether these effects varied across patients and how Part D was associated with length of stay and inpatient expenditures. We used Medicare claims and the Medicare Current Beneficiary Survey from 2002 to 2010 and an instrumental variables approach. Gaining drug insurance through Part D was associated with a statistically significant 8.0% reduction in likelihood of admission across conditions examined. Reductions were generally greater for younger, healthier, and male individuals. Across all conditions, mean length of stay decreased by 3.2% from a baseline of 5.1 days. Part D was associated with a 3.5% reduction in expenditures per admission, reflecting a decrease of $844 from a mean charge of $24,124 per admission prior to Part D. Thus, Part D was associated with statistically and clinically significant reductions in the probability of admission and length of stay for several common conditions.

scholarly journals Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes

2015 ◽  
Vol 22 (5) ◽  
pp. 1094-1098 ◽  
Author(s):  
Christopher Powers ◽  
Meghan Hufstader Gabriel ◽  
William Encinosa ◽  
Farzad Mostashari ◽  
Julie Bynum
Keyword(s):  
Adverse Drug Events ◽  
Meaningful Use ◽  
Medicare Part D ◽  
Medicare Part ◽  
Ambulatory Setting ◽  
Diabetic Patients ◽  
Medicare Beneficiaries ◽  
Part D ◽  
Use Stage ◽  
Reduced Risk

Abstract Evidence supports the potential for e-prescribing to reduce the incidence of adverse drug events (ADEs) in hospital-based studies, but studies in the ambulatory setting have not used occurrence of ADE as their outcome. Using the “prescription origin code” in 2011 Medicare Part D prescription drug events files, the authors investigate whether physicians who meet the meaningful use stage 2 threshold for e-prescribing (≥50% of prescriptions e-prescribed) have lower rates of ADEs among their diabetic patients. Risk of any patient with diabetes in the provider’s panel having an ADE from anti-diabetic medications was modeled adjusted for prescriber and patient panel characteristics. Physician e-prescribing to Medicare beneficiaries was associated with reduced risk of ADEs among their diabetes patients (Odds Ratio: 0.95; 95% CI, 0.94-0.96), as were several prescriber and panel characteristics. However, these physicians treated fewer patients from disadvantaged populations.

Sign in / Sign up

Export Citation Format

Share Document